{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T05:59:41Z","timestamp":1768283981571,"version":"3.49.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T00:00:00Z","timestamp":1617840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T00:00:00Z","timestamp":1617840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/http:\/\/dx.doi.org\/10.13039\/100009945","name":"Merck KGaA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/http:\/\/dx.doi.org\/10.13039\/100009945","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s12020-021-02687-0","type":"journal-article","created":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T04:02:52Z","timestamp":1617854572000},"page":"699-710","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Metformin in non-diabetic patients with metabolic syndrome and diastolic dysfunction: the MET-DIME randomized trial"],"prefix":"10.1007","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5260-5613","authenticated-orcid":false,"given":"Ricardo","family":"Ladeiras-Lopes","sequence":"first","affiliation":[]},{"given":"Francisco","family":"Sampaio","sequence":"additional","affiliation":[]},{"given":"Sara","family":"Leite","sequence":"additional","affiliation":[]},{"given":"Diogo","family":"Santos-Ferreira","sequence":"additional","affiliation":[]},{"given":"Eduardo","family":"Vilela","sequence":"additional","affiliation":[]},{"given":"Adelino","family":"Leite-Moreira","sequence":"additional","affiliation":[]},{"given":"Nuno","family":"Bettencourt","sequence":"additional","affiliation":[]},{"given":"Vasco","family":"Gama","sequence":"additional","affiliation":[]},{"given":"Pedro","family":"Braga","sequence":"additional","affiliation":[]},{"given":"Ricardo","family":"Fontes-Carvalho","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2021,4,8]]},"reference":[{"issue":"9468","key":"2687_CR1","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","volume":"365","author":"RH Eckel","year":"2005","unstructured":"R.H. Eckel, S.M. Grundy, P.Z. Zimmet, The metabolic syndrome. Lancet 365(9468), 1415\u20131428 (2005). https:\/\/doi.org\/10.1016\/S0140-6736(05)66378-7","journal-title":"Lancet"},{"key":"2687_CR2","doi-asserted-by":"publisher","first-page":"E24","DOI":"10.5888\/pcd14.160287","volume":"14","author":"JX Moore","year":"2017","unstructured":"J.X. Moore, N. Chaudhary, T. Akinyemiju, Metabolic syndrome prevalence by race\/ethnicity and sex in the United States, National Health and Nutrition Examination Survey, 1988-2012. Prev. Chronic Dis. 14, E24 (2017). https:\/\/doi.org\/10.5888\/pcd14.160287","journal-title":"Prev. Chronic Dis."},{"key":"2687_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.trsl.2017.01.001","volume":"183","author":"JD Tune","year":"2017","unstructured":"J.D. Tune, A.G. Goodwill, D.J. Sassoon, K.J. Mather, Cardiovascular consequences of metabolic syndrome. Transl. Res. 183, 57\u201370 (2017). https:\/\/doi.org\/10.1016\/j.trsl.2017.01.001","journal-title":"Transl. Res."},{"issue":"6","key":"2687_CR4","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1093\/ejechocard\/jer291","volume":"13","author":"W Kosmala","year":"2012","unstructured":"W. Kosmala, M. Przewlocka-Kosmala, A. Wojnalowicz, A. Mysiak, T.H. Marwick, Integrated backscatter as a fibrosis marker in the metabolic syndrome: association with biochemical evidence of fibrosis and left ventricular dysfunction. Eur. Heart J. Cardiovasc. Imaging 13(6), 459\u2013467 (2012). https:\/\/doi.org\/10.1093\/ejechocard\/jer291","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"issue":"5","key":"2687_CR5","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.2337\/db17-1496","volume":"67","author":"R Ladeiras-Lopes","year":"2018","unstructured":"R. Ladeiras-Lopes, H.T. Moreira, N. Bettencourt, R. Fontes-Carvalho, F. Sampaio, B. Ambale-Venkatesh, C. Wu, K. Liu, A.G. Bertoni, P. Ouyang, D.A. Bluemke, J.A. Lima, Metabolic syndrome is associated with impaired diastolic function independently of MRI-derived myocardial extracellular volume: the MESA study. Diabetes 67(5), 1007\u20131012 (2018). https:\/\/doi.org\/10.2337\/db17-1496","journal-title":"Diabetes"},{"key":"2687_CR6","doi-asserted-by":"publisher","unstructured":"R. Ladeiras-Lopes, M. Araujo, F. Sampaio, A. Leite-Moreira, R. Fontes-Carvalho. The impact of diastolic dysfunction as a predictor of cardiovascular events: a systematic review and meta-analysis. Rev. Port. Cardiol. (2020). https:\/\/doi.org\/10.1016\/j.repc.2019.03.007","DOI":"10.1016\/j.repc.2019.03.007"},{"issue":"6","key":"2687_CR7","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMoa012512","volume":"346","author":"WC Knowler","year":"2002","unstructured":"W.C. Knowler, E. Barrett-Connor, S.E. Fowler, R.F. Hamman, J.M. Lachin, E.A. Walker, D.M. Nathan; Diabetes Prevention Program Research, G., Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346(6), 393\u2013403 (2002). https:\/\/doi.org\/10.1056\/NEJMoa012512","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"2687_CR8","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1517\/14728222.2015.1025051","volume":"19","author":"R Ladeiras-Lopes","year":"2015","unstructured":"R. Ladeiras-Lopes, R. Fontes-Carvalho, N. Bettencourt, F. Sampaio, V. Gama, A. Leite-Moreira, Novel therapeutic targets of metformin: metabolic syndrome and cardiovascular disease. Expert Opin. Ther. Targets 19(7), 869\u2013877 (2015). https:\/\/doi.org\/10.1517\/14728222.2015.1025051","journal-title":"Expert Opin. Ther. Targets"},{"issue":"1","key":"2687_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1440-1681.2010.05461.x","volume":"38","author":"CX Zhang","year":"2011","unstructured":"C.X. Zhang, S.N. Pan, R.S. Meng, C.Q. Peng, Z.J. Xiong, B.L. Chen, G.Q. Chen, F.J. Yao, Y.L. Chen, Y.D. Ma, Y.G. Dong, Metformin attenuates ventricular hypertrophy by activating the AMP-activated protein kinase-endothelial nitric oxide synthase pathway in rats. Clin. Exp. Pharm. Physiol. 38(1), 55\u201362 (2011). https:\/\/doi.org\/10.1111\/j.1440-1681.2010.05461.x","journal-title":"Clin. Exp. Pharm. Physiol."},{"issue":"3","key":"2687_CR10","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1093\/cvr\/cvq066","volume":"87","author":"H Xiao","year":"2010","unstructured":"H. Xiao, X. Ma, W. Feng, Y. Fu, Z. Lu, M. Xu, Q. Shen, Y. Zhu, Y. Zhang, Metformin attenuates cardiac fibrosis by inhibiting the TGFbeta1-Smad3 signalling pathway. Cardiovasc. Res. 87(3), 504\u2013513 (2010). https:\/\/doi.org\/10.1093\/cvr\/cvq066","journal-title":"Cardiovasc. Res."},{"issue":"2","key":"2687_CR11","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s10557-014-6512-2","volume":"28","author":"R Ladeiras-Lopes","year":"2014","unstructured":"R. Ladeiras-Lopes, R. Fontes-Carvalho, N. Bettencourt, F. Sampaio, V. Gama, A.F. Leite-Moreira, METformin in diastolic dysfunction of MEtabolic syndrome (MET-DIME) trial: rationale and study design: MET-DIME trial. Cardiovasc. Drugs Ther. 28(2), 191\u2013196 (2014). https:\/\/doi.org\/10.1007\/s10557-014-6512-2","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"17","key":"2687_CR12","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","volume":"112","author":"SM Grundy","year":"2005","unstructured":"S.M. Grundy, J.I. Cleeman, S.R. Daniels, K.A. Donato, R.H. Eckel, B.A. Franklin, D.J. Gordon, R.M. Krauss, P.J. Savage, S.C. Smith Jr., J.A. Spertus, F. Costa; American Heart, A., National Heart, L., Blood, I., Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112(17), 2735\u20132752 (2005). https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.169404","journal-title":"Circulation"},{"issue":"2","key":"2687_CR13","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/ejechocard\/jep007","volume":"10","author":"SF Nagueh","year":"2009","unstructured":"S.F. Nagueh, C.P. Appleton, T.C. Gillebert, P.N. Marino, J.K. Oh, O.A. Smiseth, A.D. Waggoner, F.A. Flachskampf, P.A. Pellikka, A. Evangelisa, Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur. J. Echocardiogr. 10(2), 165\u2013193 (2009). https:\/\/doi.org\/10.1093\/ejechocard\/jep007","journal-title":"Eur. J. Echocardiogr."},{"issue":"Suppl 1","key":"2687_CR14","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.2337\/dc12-s011","volume":"35","author":"American Diabetes, A.","year":"2012","unstructured":"American Diabetes, A., Standards of medical care in diabetes-\u22122012. Diabetes Care 35(Suppl 1), S11\u2013S63 (2012). https:\/\/doi.org\/10.2337\/dc12-s011","journal-title":"Diabetes Care"},{"issue":"1","key":"2687_CR15","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2307\/2529712","volume":"31","author":"SJ Pocock","year":"1975","unstructured":"S.J. Pocock, R. Simon, Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 31(1), 103\u2013115 (1975)","journal-title":"Biometrics"},{"issue":"14","key":"2687_CR16","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"JJ McMurray","year":"2012","unstructured":"J.J. McMurray, S. Adamopoulos, S.D. Anker, A. Auricchio, M. Bohm, K. Dickstein, V. Falk, G. Filippatos, C. Fonseca, M.A. Gomez-Sanchez, T. Jaarsma, L. Kober, G.Y. Lip, A.P. Maggioni, A. Parkhomenko, B.M. Pieske, B.A. Popescu, P.K. Ronnevik, F.H. Rutten, J. Schwitter, P. Seferovic, J. Stepinska, P.T. Trindade, A.A. Voors, F. Zannad, A. Zeiher, E.S.C.Cf.P. Guidelines, ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur. Heart J. 33(14), 1787\u20131847 (2012). https:\/\/doi.org\/10.1093\/eurheartj\/ehs104","journal-title":"Eur. Heart J."},{"issue":"3","key":"2687_CR17","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/ehjci\/jev014","volume":"16","author":"RM Lang","year":"2015","unstructured":"R.M. Lang, L.P. Badano, V. Mor-Avi, J. Afilalo, A. Armstrong, L. Ernande, F.A. Flachskampf, E. Foster, S.A. Goldstein, T. Kuznetsova, P. Lancellotti, D. Muraru, M.H. Picard, E.R. Rietzschel, L. Rudski, K.T. Spencer, W. Tsang, J.U. Voigt, Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur. Heart J. Cardiovasc. Imaging 16(3), 233\u2013270 (2015). https:\/\/doi.org\/10.1093\/ehjci\/jev014","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"issue":"1-2","key":"2687_CR18","first-page":"55","volume":"13","author":"PL Ferreira","year":"2000","unstructured":"P.L. Ferreira,, Development of the Portuguese version of MOS SF-36. Part I. Cultural and linguistic adaptation. Acta Med. Port. 13(1-2), 55\u201366 (2000).","journal-title":"Acta Med. Port."},{"issue":"3","key":"2687_CR19","first-page":"119","volume":"13","author":"PL Ferreira","year":"2000","unstructured":"P.L. Ferreira,, Development of the Portuguese version of MOS SF-36. Part II -Validation tests. Acta Med. Port. 13(3), 119\u2013127 (2000).","journal-title":"Acta Med. Port."},{"issue":"5","key":"2687_CR20","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.cjca.2017.12.030","volume":"34","author":"AK Khetan","year":"2018","unstructured":"A.K. Khetan, S. Rajagopalan, Prediabetes. Can. J. Cardiol. 34(5), 615\u2013623 (2018). https:\/\/doi.org\/10.1016\/j.cjca.2017.12.030","journal-title":"Can. J. Cardiol."},{"issue":"5","key":"2687_CR21","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1093\/eurheartj\/ehl526","volume":"28","author":"L de las Fuentes","year":"2007","unstructured":"L. de las Fuentes, A.L. Brown, S.J. Mathews, A.D. Waggoner, P.F. Soto, R.J. Gropler, V.G. Davila-Roman, Metabolic syndrome is associated with abnormal left ventricular diastolic function independent of left ventricular mass. Eur. Heart J. 28(5), 553\u2013559 (2007). https:\/\/doi.org\/10.1093\/eurheartj\/ehl526","journal-title":"Eur. Heart J."},{"issue":"3","key":"2687_CR22","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/s0735-1097(00)00786-5","volume":"36","author":"K Shan","year":"2000","unstructured":"K. Shan, R.J. Bick, B.J. Poindexter, S. Shimoni, G.V. Letsou, M.J. Reardon, J.F. Howell, W.A. Zoghbi, S.F. Nagueh, Relation of tissue Doppler derived myocardial velocities to myocardial structure and beta-adrenergic receptor density in humans. J. Am. Coll. Cardiol. 36(3), 891\u2013896 (2000). https:\/\/doi.org\/10.1016\/s0735-1097(00)00786-5","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"2687_CR23","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s40256-018-0266-3","volume":"18","author":"L Varjabedian","year":"2018","unstructured":"L. Varjabedian, M. Bourji, L. Pourafkari, N.D. Nader, Cardioprotection by metformin: beneficial effects beyond glucose reduction. Am. J. Cardiovasc. Drugs 18(3), 181\u2013193 (2018). https:\/\/doi.org\/10.1007\/s40256-018-0266-3","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"2687_CR24","doi-asserted-by":"publisher","unstructured":"Han, X., Wang, Y., Fu, M., Song, Y., Wang, J., Cui, X., Fan, Y., Cao, J., Luo, J., Sun, A., Zou, Y., Hu, K., Zhou, J., Ge, J.: Effects of Adiponectin on Diastolic Function in Mice Underwent Transverse Aorta Constriction. J Cardiovasc Transl Res (2019). https:\/\/doi.org\/10.1007\/s12265-019-09913-1","DOI":"10.1007\/s12265-019-09913-1"},{"key":"2687_CR25","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.ejphar.2017.08.042","volume":"814","author":"Y Chen","year":"2017","unstructured":"Y. Chen, C. Chen, B. Dong, F. Xing, H. Huang, F. Yao, Y. Ma, J. He, Y. Dong, AMPK attenuates ventricular remodeling and dysfunction following aortic banding in mice via the Sirt3\/Oxidative stress pathway. Eur. J. Pharm. 814, 335\u2013342 (2017). https:\/\/doi.org\/10.1016\/j.ejphar.2017.08.042","journal-title":"Eur. J. Pharm."},{"issue":"8","key":"2687_CR26","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1139\/cjpp-2018-0737","volume":"97","author":"MP Morissette","year":"2019","unstructured":"M.P. Morissette, S.E. Susser, A.N. Stammers, T.L. Moffatt, J.T. Wigle, T.J. Wigle, T. Netticadan, S. Premecz, D.S. Jassal, K.A. O\u2019Hara, T.A. Duhamel, Exercise-induced increases in the expression and activity of cardiac sarcoplasmic reticulum calcium ATPase 2 is attenuated in AMPKalpha2 kinase-dead mice. Can. J. Physiol. Pharm. 97(8), 786\u2013795 (2019). https:\/\/doi.org\/10.1139\/cjpp-2018-0737","journal-title":"Can. J. Physiol. Pharm."},{"issue":"2","key":"2687_CR27","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.peptides.2008.10.018","volume":"30","author":"R Ladeiras-Lopes","year":"2009","unstructured":"R. Ladeiras-Lopes, J. Ferreira-Martins, A.F. Leite-Moreira, Acute neurohumoral modulation of diastolic function. Peptides 30(2), 419\u2013425 (2009). https:\/\/doi.org\/10.1016\/j.peptides.2008.10.018","journal-title":"Peptides"},{"issue":"2","key":"2687_CR28","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.numecd.2019.09.005","volume":"30","author":"PWC Oliveira","year":"2020","unstructured":"P.W.C. Oliveira, G.J. de Sousa, A.M. Birocale, S.A. Gouvea, S.G. de Figueiredo, G.R. de Abreu, N.S. Bissoli, Chronic metformin reduces systemic and local inflammatory proteins and improves hypertension-related cardiac autonomic dysfunction. Nutr. Metab. Cardiovasc. Dis. 30(2), 274\u2013281 (2020). https:\/\/doi.org\/10.1016\/j.numecd.2019.09.005","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"2","key":"2687_CR29","doi-asserted-by":"publisher","first-page":"H459","DOI":"10.1152\/ajpheart.00054.2011","volume":"301","author":"M Yin","year":"2011","unstructured":"M. Yin, I.C. van der Horst, J.P. van Melle, C. Qian, W.H. van Gilst, H.H. Sillje, R.A. de Boer, Metformin improves cardiac function in a nondiabetic rat model of post-MI heart failure. Am. J. Physiol. Heart Circ. Physiol. 301(2), H459\u2013H468 (2011). https:\/\/doi.org\/10.1152\/ajpheart.00054.2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"41","key":"2687_CR30","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.1093\/eurheartj\/ehz203","volume":"40","author":"M Mohan","year":"2019","unstructured":"M. Mohan, S. Al-Talabany, A. McKinnie, I.R. Mordi, J.S.S. Singh, S.J. Gandy, F. Baig, M.S. Hussain, U. Bhalraam, F. Khan, A.M. Choy, S. Matthew, J.G. Houston, A.D. Struthers, J. George, C.C. Lang, A randomized controlled trial of metformin on left ventricular hypertrophy in patients with coronary artery disease without diabetes: the MET-REMODEL trial. Eur. Heart J. 40(41), 3409\u20133417 (2019). https:\/\/doi.org\/10.1093\/eurheartj\/ehz203","journal-title":"Eur. Heart J."},{"issue":"4","key":"2687_CR31","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00380-006-0961-x","volume":"22","author":"S Terzi","year":"2007","unstructured":"S. Terzi, N. Sayar, T. Bilsel, Y. Enc, A. Yildirim, F. Ciloglu, K. Yesilcimen, Tissue Doppler imaging adds incremental value in predicting exercise capacity in patients with congestive heart failure. Heart Vessels 22(4), 237\u2013244 (2007). https:\/\/doi.org\/10.1007\/s00380-006-0961-x","journal-title":"Heart Vessels"},{"issue":"2","key":"2687_CR32","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1093\/ehjci\/jeu277","volume":"16","author":"NE Hasselberg","year":"2015","unstructured":"N.E. Hasselberg, K.H. Haugaa, S.I. Sarvari, L. Gullestad, A.K. Andreassen, O.A. Smiseth, T. Edvardsen, Left ventricular global longitudinal strain is associated with exercise capacity in failing hearts with preserved and reduced ejection fraction. Eur. Heart J. Cardiovasc. Imaging 16(2), 217\u2013224 (2015). https:\/\/doi.org\/10.1093\/ehjci\/jeu277","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"issue":"1","key":"2687_CR33","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2337\/diacare.23.1.57","volume":"23","author":"E Bonora","year":"2000","unstructured":"E. Bonora, G. Targher, M. Alberiche, R.C. Bonadonna, F. Saggiani, M.B. Zenere, T. Monauni, M. Muggeo, Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23(1), 57\u201363 (2000). https:\/\/doi.org\/10.2337\/diacare.23.1.57","journal-title":"Diabetes Care"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02687-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-021-02687-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02687-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T12:46:25Z","timestamp":1622119585000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-021-02687-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,8]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["2687"],"URL":"https:\/\/doi.org\/10.1007\/s12020-021-02687-0","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,8]]},"assertion":[{"value":"24 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This randomized trial was approved by the Local Ethics Committee, Portuguese Data Protection Agency, INFARMED (National Pharmacy and Medicines Institute) and CEIC (National Ethics Committee for Clinical Research). It is registered in www.clinicaltrials.gov with the Identifier NCT02017561. The study was conducted in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}